Nuveen Asset Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-412,439
| Closed | -$8.32M | – | 3353 |
|
|
2021
Q3 | $8.32M | Sell |
412,439
-53,014
| -11% | -$1.07M | ﹤0.01% | 1903 |
|
|
2021
Q2 | $17.4M | Buy |
465,453
+135,843
| +41% | +$5.07M | 0.01% | 1483 |
|
|
2021
Q1 | $8.43M | Sell |
329,610
-42,064
| -11% | -$1.08M | ﹤0.01% | 1890 |
|
|
2020
Q4 | $8.19M | Sell |
371,674
-33,119
| -8% | -$730K | ﹤0.01% | 1829 |
|
|
2020
Q3 | $7.28M | Buy |
404,793
+45,431
| +13% | +$817K | ﹤0.01% | 1713 |
|
|
2020
Q2 | $9.13M | Sell |
359,362
-32,848
| -8% | -$834K | ﹤0.01% | 1541 |
|
|
2020
Q1 | $7.21M | Buy |
392,210
+868
| +0.2% | +$15.9K | ﹤0.01% | 1494 |
|
|
2019
Q4 | $8.62M | Buy |
391,342
+88,054
| +29% | +$1.94M | ﹤0.01% | 1673 |
|
|
2019
Q3 | $4.36M | Buy |
303,288
+49,732
| +20% | +$714K | ﹤0.01% | 2032 |
|
|
2019
Q2 | $3.99M | Buy |
+253,556
| New | +$3.99M | ﹤0.01% | 2103 |
|